
Pulled from Benzinga Pro data, Amphastar Pharmaceuticals (NASDAQ:AMPH) posted Q1 earnings of $24.25 million, an increase from Q4 of 22.74%. Sales dropped to $120.37 million, a 0.43% decrease between quarters. In Q4, Amphastar Pharmaceuticals brought in $120.89 million in sales but only earned $19.76 million.